Mary Kay Fenton

2013 - Achillion Pharmaceuticals

In 2013, Mary Kay Fenton earned a total compensation of $989.6K as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals, a 28% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$74,256
Option Awards$580,968
Salary$326,400
Other$7,992
Total$989,616

Fenton received $581K in option awards, accounting for 59% of the total pay in 2013.

Fenton also received $74.3K in non-equity incentive plan, $326.4K in salary and $8K in other compensation.

Rankings

In 2013, Mary Kay Fenton's compensation ranked 6,668th out of 12,286 executives tracked by ExecPay. In other words, Fenton earned more than 45.7% of executives.

ClassificationRankingPercentile
All
6,668
out of 12,286
46th
Division
Manufacturing
2,351
out of 4,612
49th
Major group
Chemicals And Allied Products
701
out of 1,462
52nd
Industry group
Drugs
512
out of 1,156
56th
Industry
Pharmaceutical Preparations
406
out of 890
54th
Source: SEC filing on April 15, 2016.

Fenton's colleagues

We found five more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2013.

2013

Milind Deshpande

Achillion Pharmaceuticals

Chief Executive Officer

2013

David Apelian

Achillion Pharmaceuticals

Chief Medical Officer

2013

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

2013

Gautam Shah

Achillion Pharmaceuticals

Former Executive Vice President and Chief Compliance Officer

2013

Michael Kishbauch

Achillion Pharmaceuticals

Chief Executive Officer

News

In-depth

You may also like